A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI) is used for the patients with EGFR-mutant lung cancer. Recently, phase III studies in the patients with EGFR-mutant demonstrated that EGFR-TKI mon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tanaka, Hisashi, Hayashi, Akihito, Morimoto, Takeshi, Taima, Kageaki, Tanaka, Yoshihito, Shimada, Michiko, Kurose, Akira, Takanashi, Shingo, Okumura, Ken
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3515412/
https://ncbi.nlm.nih.gov/pubmed/23181703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-558
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak